2024 ICD-10-CM Diagnosis Code T50.3X1

Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional)

ICD-10-CM Code:
T50.3X1
ICD-10 Code for:
Poisoning by electrolytic/caloric/wtr-bal agnt, accidental
Is Billable?
Not Valid for Submission
Code Navigator:

Code Classification

  • Injury, poisoning and certain other consequences of external causes
    (S00–T88)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
      (T36-T50)
      • Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances
        (T50)

T50.3X1 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional). The code is not specific and is NOT valid for the year 2024 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Specific Coding Applicable to Poisoning by electrolytic/caloric/wtr-bal agnt, accidental

Non-specific codes like T50.3X1 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10-CM codes with a higher level of specificity when coding for poisoning by electrolytic/caloric/wtr-bal agnt, accidental:

  • Use T50.3X1A for initial encounter - BILLABLE CODE

  • Use T50.3X1D for subsequent encounter - BILLABLE CODE

  • Use T50.3X1S for sequela - BILLABLE CODE

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Accidental electrolyte agent poisoning
  • Accidental potassium overdose
  • Accidental tryptophan overdose
  • Accidental tryptophan poisoning
  • Electrolyte agent poisoning
  • Potassium overdose
  • Potassium poisoning
  • Sodium chloride poisoning
  • Tryptophan overdose
  • Tryptophan poisoning

Clinical Information

  • Amino Acids

    organic compounds that generally contain an amino (-nh2) and a carboxyl (-cooh) group. twenty alpha-amino acids are the subunits which are polymerized to form proteins.
  • Amino Acids, Acidic

    amino acids with side chains that are negatively charged at physiological ph.
  • Amino Acids, Aromatic

    amino acids containing an aromatic side chain.
  • Amino Acids, Basic

    amino acids with side chains that are positively charged at physiological ph.
  • Amino Acids, Branched-Chain

    amino acids which have a branched carbon chain.
  • Amino Acids, Cyclic

    a class of amino acids characterized by a closed ring structure.
  • Amino Acids, Diamino

  • Amino Acids, Dicarboxylic

  • Amino Acids, Essential

    amino acids that are not synthesized by the human body in amounts sufficient to carry out physiological functions. they are obtained from dietary foodstuffs.
  • Amino Acids, Neutral

    amino acids with uncharged r groups or side chains.
  • Amino Acids, Peptides, and Proteins

    amino acids and chains of amino acids connected by peptide linkages.
  • Amino Acids, Sulfur

  • Aminoacylation

    a reaction that introduces an aminoacyl group to a molecule. transfer rna aminoacylation is the first step in genetic translation.
  • Excitatory Amino Acid Agents

    drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neurons using excitatory amino acids.
  • Excitatory Amino Acid Agonists

    drugs that bind to and activate excitatory amino acid receptors.
  • Excitatory Amino Acid Antagonists

    drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
  • Excitatory Amino Acids

    endogenous amino acids released by neurons as excitatory neurotransmitters. glutamic acid is the most common excitatory neurotransmitter in the brain. aspartic acid has been regarded as an excitatory transmitter for many years, but the extent of its role as a transmitter is unclear.
  • Imino Acids

    carboxylic acids that contain an imino group (c=nh).
  • Phosphoamino Acids

    amino acids that contain phosphorus as an integral part of the molecule.
  • Receptors, Amino Acid

    cell surface proteins that bind amino acids and trigger changes which influence the behavior of cells. glutamate receptors are the most common receptors for fast excitatory synaptic transmission in the vertebrate central nervous system, and gamma-aminobutyric acid and glycine receptors are the most common receptors for fast inhibition.
  • Acamprosate

    structural analog of taurine that is used for the prevention of relapse in individuals with alcoholism.
  • Alginates

    salts and esters of alginic acid that are used as hydrogels; dental impression materials, and as absorbent materials for surgical dressings (bandages, hydrocolloid). they are also used to manufacture microspheres and nanoparticles for diagnostic reagent kits and drug delivery systems.
  • Annexin A6

    protein of the annexin family with a probable role in exocytotic and endocytotic membrane events.
  • Aspartic Acid

    one of the non-essential amino acids commonly occurring in the l-form. it is found in animals and plants, especially in sugar cane and sugar beets. it may be a neurotransmitter.
  • Bilirubin

    a bile pigment that is a degradation product of heme.
  • Ca(2+) Mg(2+)-ATPase

    an enzyme that catalyzes the hydrolysis of atp and is activated by millimolar concentrations of either ca(2+) or mg(2+). unlike ca(2+)-transporting atpase it does not require the second divalent cation for its activity, and is not sensitive to orthovanadate. (prog biophys mol biol 1988;52(1):1). a subgroup of ec 3.6.1.3.
  • Calcium

    a basic element found in nearly all tissues. it is a member of the alkaline earth family of metals with the atomic symbol ca, atomic number 20, and atomic weight 40. calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. it is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor iv) and in many enzymatic processes.
  • Calcium Aluminosilicate

    aluminosilicate salts of calcium, the most common of which are caal2si2o8 and ca2al2sio7; a naturally occurring form in clay may be used to treat diarrhea.
  • Calcium Carbonate

    carbonic acid calcium salt (caco3). an odorless, tasteless powder or crystal that occurs in nature. it is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement.
  • Calcium Channel Agonists

    agents that increase calcium influx into calcium channels of excitable tissues. this causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. they have been used primarily in experimental studies in cell and tissue culture.
  • Calcium Channel Blockers

    a class of drugs that act by selective inhibition of calcium influx through cellular membranes.
  • Calcium Channels

    voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. they are categorized as l-, t-, n-, p-, q-, and r-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. the l- and t-types are present throughout the cardiovascular and central nervous systems and the n-, p-, q-, & r-types are located in neuronal tissue.
  • Calcium Channels, L-Type

    long-lasting voltage-gated calcium channels found in both excitable and non-excitable tissue. they are responsible for normal myocardial and vascular smooth muscle contractility. five subunits (alpha-1, alpha-2, beta, gamma, and delta) make up the l-type channel. the alpha-1 subunit is the binding site for calcium-based antagonists. dihydropyridine-based calcium antagonists are used as markers for these binding sites.
  • Calcium Channels, N-Type

    calcium channels that are concentrated in neural tissue. omega toxins inhibit the actions of these channels by altering their voltage dependence.
  • Calcium Channels, P-Type

    calcium channels located within the purkinje cells of the cerebellum. they are involved in stimulation-secretion coupling of neurons.
  • Calcium Channels, Q-Type

    calcium channels located in the neurons of the brain.
  • Calcium Channels, R-Type

    calcium channels located in the neurons of the brain. they are inhibited by the marine snail toxin, omega conotoxin mviic.
  • Calcium Channels, T-Type

    a heterogenous group of transient or low voltage activated type calcium channels. they are found in cardiac myocyte membranes, the sinoatrial node, purkinje cells of the heart and the central nervous system.
  • Calcium Chelating Agents

    substances that bind to and sequester calcium ions.
  • Calcium Chloride

    a salt used to replenish calcium levels, as an acid-producing diuretic, and as an antidote for magnesium poisoning.
  • Calcium Citrate

    a colorless crystalline or white powdery organic, tricarboxylic acid occurring in plants, especially citrus fruits, and used as a flavoring agent, as an antioxidant in foods, and as a sequestrating agent. (mcgraw-hill dictionary of scientific and technical terms, 4th ed)
  • Calcium Compounds

    inorganic compounds that contain calcium as an integral part of the molecule.
  • Calcium Dobesilate

    a drug used to reduce hemorrhage in diabetic retinopathy.
  • Calcium Fluoride

    calcium fluoride. occurring in nature as the mineral fluorite or fluorspar. it is the primary source of fluorine and its compounds. pure calcium fluoride is used as a catalyst in dehydration and dehydrogenation and is used to fluoridate drinking water. (from merck index, 11th ed)
  • Calcium Gluconate

    the calcium salt of gluconic acid. the compound has a variety of uses, including its use as a calcium replenisher in hypocalcemic states.
  • Calcium Hydroxide

    a white powder prepared from lime that has many medical and industrial uses. it is in many dental formulations, especially for root canal filling.
  • Calcium Ionophores

    chemical agents that increase the permeability of cell membranes to calcium ions.
  • Calcium Isotopes

    stable calcium atoms that have the same atomic number as the element calcium, but differ in atomic weight. ca-42-44, 46, and 48 are stable calcium isotopes.
  • Calcium Metabolism Disorders

    disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.
  • Calcium Oxalate

    the calcium salt of oxalic acid, occurring in the urine as crystals and in certain calculi.
  • Calcium Phosphates

    calcium salts of phosphoric acid. these compounds are frequently used as calcium supplements.
  • Calcium Pyrophosphate

    an inorganic pyrophosphate which affects calcium metabolism in mammals. abnormalities in its metabolism occur in some human diseases, notably hypophosphatasia and pseudogout (chondrocalcinosis).
  • Calcium Radioisotopes

    unstable isotopes of calcium that decay or disintegrate emitting radiation. ca atoms with atomic weights 39, 41, 45, 47, 49, and 50 are radioactive calcium isotopes.
  • Calcium Release Activated Calcium Channels

    specialized calcium channels that localize to the endoplamsic reticulum and plasma membrane. they contain the pore subunit orai1 protein which is activated by stromal interaction molecules upon intracellular calcium depletion.
  • Calcium Signaling

    signal transduction mechanisms whereby calcium mobilization (from outside the cell or from intracellular storage pools) to the cytoplasm is triggered by external stimuli. calcium signals are often seen to propagate as waves, oscillations, spikes, sparks, or puffs. the calcium acts as an intracellular messenger by activating calcium-responsive proteins.
  • Calcium Sulfate

    a calcium salt that is used for a variety of purposes including: building materials, as a desiccant, in dentistry as an impression material, cast, or die, and in medicine for immobilizing casts and as a tablet excipient. it exists in various forms and states of hydration. plaster of paris is a mixture of powdered and heat-treated gypsum.
  • Calcium, Dietary

    calcium compounds in dietary supplements or in food that supply the body with calcium.
  • Calcium-Binding Proteins

    proteins to which calcium ions are bound. they can act as transport proteins, regulator proteins, or activator proteins. they typically contain ef hand motifs.
  • Calcium-Calmodulin-Dependent Protein Kinase Kinase

    a regulatory calcium-calmodulin-dependent protein kinase that specifically phosphorylates calcium-calmodulin-dependent protein kinase type 1; calcium-calmodulin-dependent protein kinase type 2; calcium-calmodulin-dependent protein kinase type 4; and protein kinase b. it is a monomeric enzyme that is encoded by at least two different genes.
  • Calcium-Calmodulin-Dependent Protein Kinase Type 1

    a monomeric calcium-calmodulin-dependent protein kinase subtype that is expressed in a broad variety of mammalian cell types. its expression is regulated by the action of calcium-calmodulin-dependent protein kinase kinase. several isoforms of this enzyme subtype are encoded by distinct genes.
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2

    a multifunctional calcium-calmodulin-dependent protein kinase subtype that occurs as an oligomeric protein comprised of twelve subunits. it differs from other enzyme subtypes in that it lacks a phosphorylatable activation domain that can respond to calcium-calmodulin-dependent protein kinase kinase.
  • Calcium-Calmodulin-Dependent Protein Kinase Type 4

    a monomeric calcium-calmodulin-dependent protein kinase subtype that is primarily expressed in neuronal tissues; t-lymphocytes and testis. the activity of this enzyme is regulated by its phosphorylation by calcium-calmodulin-dependent protein kinase kinase.
  • Calcium-Calmodulin-Dependent Protein Kinases

    a calmodulin-dependent enzyme that catalyzes the phosphorylation of proteins. this enzyme is also sometimes dependent on calcium. a wide range of proteins can act as acceptor, including vimentin; synapsins; glycogen synthase; myosin light chains; and the microtubule-associated proteins. (from enzyme nomenclature, 1992, p277)
  • Calcium-Regulating Hormones and Agents

    hormones and molecules with calcium-regulating hormone-like actions that modulate osteolysis and other extra-skeletal activities to maintain calcium homeostasis.
  • Calcium-Transporting ATPases

    cation-transporting proteins that utilize the energy of atp hydrolysis for the transport of calcium. they differ from calcium channels which allow calcium to pass through a membrane without the use of energy.
  • Calmodulin

    a heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. the binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. thereby this protein modulates cyclic amp and cyclic gmp levels.
  • Calpain

    cysteine proteinase found in many tissues. hydrolyzes a variety of endogenous proteins including neuropeptides; cytoskeletal proteins; proteins from smooth muscle; cardiac muscle; liver; platelets; and erythrocytes. two subclasses having high and low calcium sensitivity are known. removes z-discs and m-lines from myofibrils. activates phosphorylase kinase and cyclic nucleotide-independent protein kinase. this enzyme was formerly listed as ec 3.4.22.4.
  • Calreticulin

    a multifunctional protein that is found primarily within membrane-bound organelles. in the endoplasmic reticulum it binds to specific n-linked oligosaccharides found on newly-synthesized proteins and functions as a molecular chaperone that may play a role in protein folding or retention and degradation of misfolded proteins. in addition calreticulin is a major storage form for calcium and functions as a calcium-signaling molecule that can regulate intracellular calcium homeostasis.
  • Chloride Channels

    cell membrane glycoproteins that form channels to selectively pass chloride ions. nonselective blockers include fenamates; ethacrynic acid; and tamoxifen.
  • Chlortetracycline

    a tetracycline with a 7-chloro substitution.
  • Chondrocalcinosis

    presence of calcium pyrophosphate in the connective tissues such as the cartilaginous structures of joints. when accompanied by gout-like symptoms, it is referred to as pseudogout.
  • Cyanamide

    a cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. it often occurs as the calcium salt, sometimes also referred to as cyanamide. the citrated calcium salt is used in the treatment of alcoholism.
  • Cyclamates

    salts and esters of cyclamic acid.
  • Cyclic Nucleotide Phosphodiesterases, Type 1

    a calcium and calmodulin-dependent cyclic nucleotide phosphodiesterase subfamily. the three members of this family are referred to as type 1a, type 1b, and type 1c and are each product of a distinct gene. in addition, multiple enzyme variants of each subtype can be produced due to multiple alternative mrna splicing. although the type 1 enzymes are classified as 3',5'-cyclic-amp phosphodiesterases (ec 3.1.4.17), some members of this class have additional specificity for cyclic gmp.
  • Cystamine

    a radiation-protective agent that interferes with sulfhydryl enzymes. it may also protect against carbon tetrachloride liver damage.
  • Durapatite

    the mineral component of bones and teeth; it has been used therapeutically as a prosthetic aid and in the prevention and treatment of osteoporosis.
  • Edetic Acid

    a chelating agent that sequesters a variety of polyvalent cations such as calcium. it is used in pharmaceutical manufacturing and as a food additive.
  • Elongation Factor 2 Kinase

    a monomeric calcium-calmodulin-dependent protein kinase subtype that specifically phosphorylates peptide elongation factor 2. the enzyme lacks a phosphorylatable activation domain that can respond to calcium-calmodulin-dependent protein kinase kinase, however it is regulated by phosphorylation by protein kinase a and through intramolecular autophosphorylation.
  • Focal Adhesion Kinase 2

    a non-receptor protein-tyrosine kinase that is expressed primarily in the brain; osteoblasts; and lymphoid cells. in the central nervous system focal adhesion kinase 2 modulates ion channel function and mitogen-activated protein kinases activity.
  • Fusaric Acid

    a picolinic acid derivative isolated from various fusarium species. it has been proposed for a variety of therapeutic applications but is primarily used as a research tool. its mechanisms of action are poorly understood. it probably inhibits dopamine beta-hydroxylase, the enzyme that converts dopamine to norepinephrine. it may also have other actions, including the inhibition of cell proliferation and dna synthesis.
  • Glucaric Acid

    a sugar acid derived from d-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups.
  • Glycerophosphates

    any salt or ester of glycerophosphoric acid.
  • Glycine

    a non-essential amino acid. it is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. it is also a fast inhibitory neurotransmitter.
  • Intracellular Calcium-Sensing Proteins

    intracellular signaling peptides and proteins that bind to calcium. they undergo allosteric changes when bound to calcium that affects their interaction with other signal-transducing molecules. they differ from calcium-sensing receptors which sense extracellular calcium levels.
  • Ipodate

    ionic monomeric contrast media. usually the sodium or calcium salts are used for examination of the gall bladder and biliary tract. (from martindale, the extra pharmacopoeia, 30th ed, p704)
  • Ketoglutaric Acids

    a family of compounds containing an oxo group with the general structure of 1,5-pentanedioic acid. (from lehninger, principles of biochemistry, 1982, p442)
  • Leucovorin

    the active metabolite of folic acid. leucovorin is used principally as an antidote to folic acid antagonists.
  • Leukocyte L1 Antigen Complex

    a member of the s-100 protein family that is present at high levels in the blood and interstitial fluid in several infectious, inflammatory, and malignant disorders, including rheumatoid arthritis, inflammatory bowel disease, and cystic fibrosis. it is a complex of a light chain (calgranulin a) and a heavy chain (calgranulin b). l1 binds calcium through an ef-hand motif, and has been shown to possess antimicrobial activity.
  • Nadroparin

    a heparin fraction with a mean molecular weight of 4500 daltons. it is isolated from porcine mucosal heparin and used as an antithrombotic agent. (from merck index, 11th ed)
  • Nedocromil

    a pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with asthma, including eosinophils; neutrophils; macrophages; mast cells; monocytes; and platelets.
  • Neuronal Calcium-Sensor Proteins

    a family of intracellular calcium-sensing proteins found predominately in neurons and photoreceptor cells. they contain ef hand motifs and undergo conformational changes upon calcium-binding. neuronal calcium-sensor proteins interact with other regulatory proteins to mediate physiological responses to a change in intracellular calcium concentration.
  • Novobiocin

    an antibiotic compound derived from streptomyces niveus. it has a chemical structure similar to coumarin. novobiocin binds to dna gyrase, and blocks adenosine triphosphatase (atpase) activity. (from reynolds, martindale the extra pharmacopoeia, 30th ed, p189)
  • ORAI1 Protein

    the pore-forming subunit of calcium release activated calcium channels. it is activated by stromal interaction molecule 1 upon intracellular calcium depletion.
  • Osteocalcin

    vitamin k-dependent calcium-binding protein synthesized by osteoblasts and found primarily in bones. serum osteocalcin measurements provide a noninvasive specific marker of bone metabolism. the protein contains three residues of the amino acid gamma-carboxyglutamic acid (gla), which, in the presence of calcium, promotes binding to hydroxyapatite and subsequent accumulation in bone matrix.
  • Palmitic Acid

    a common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.
  • Pantothenic Acid

    a butyryl-beta-alanine that can also be viewed as pantoic acid complexed with beta alanine. it is incorporated into coenzyme a and protects cells against peroxidative damage by increasing the level of glutathione.
  • Pectins

    high molecular weight polysaccharides present in the cell walls of all plants. pectins cement cell walls together. they are used as emulsifiers and stabilizers in the food industry. they have been tried for a variety of therapeutic uses including as antidiarrheals, where they are now generally considered ineffective, and in the treatment of hypercholesterolemia.
  • Pentetic Acid

    an iron chelating agent with properties like edetic acid. dtpa has also been used as a chelator for other metals, such as plutonium.
  • Phospholipases A2, Calcium-Independent

    a subcategory of structurally-related phospholipases a2 that do not require calcium for activity.
  • Phytic Acid

    complexing agent for removal of traces of heavy metal ions. it acts also as a hypocalcemic agent.
  • Plasma Membrane Calcium-Transporting ATPases

    calcium-transporting atpases found on the plasma membrane that catalyze the active transport of calcium from the cytoplasm into the extracellular space. they play a role in maintaining a calcium gradient across plasma membrane.
  • Potassium Channels, Calcium-Activated

    potassium channels whose activation is dependent on intracellular calcium concentrations.
  • Protein Kinase C

    an serine-threonine protein kinase that requires the presence of physiological concentrations of calcium and membrane phospholipids. the additional presence of diacylglycerols markedly increases its sensitivity to both calcium and phospholipids. the sensitivity of the enzyme can also be increased by phorbol esters and it is believed that protein kinase c is the receptor protein of tumor-promoting phorbol esters.
  • Receptors, Calcium-Sensing

    a class of g-protein-coupled receptors that react to varying extracellular calcium levels. calcium-sensing receptors in the parathyroid glands play an important role in the maintenance of calcium homeostasis by regulating the release of parathyroid hormone. they differ from intracellular calcium-sensing proteins which sense intracellular calcium levels.
  • Rosuvastatin Calcium

    a hydroxymethylglutaryl-coa-reductase inhibitor, or statin, that reduces the plasma concentrations of ldl-cholesterol; apolipoprotein b, and triglycerides while increasing hdl-cholesterol levels in patients with hypercholesterolemia and those at risk for cardiovascular diseases.
  • Ryanodine Receptor Calcium Release Channel

    a tetrameric calcium release channel in the sarcoplasmic reticulum membrane of smooth muscle cells, acting oppositely to sarcoplasmic reticulum calcium-transporting atpases. it is important in skeletal and cardiac excitation-contraction coupling and studied by using ryanodine. abnormalities are implicated in cardiac arrhythmias and muscular diseases.
  • S100 Calcium Binding Protein G

    a calbindin protein found in many mammalian tissues, including the uterus, placenta, bone, pituitary gland, and kidneys. in intestinal enterocytes it mediates intracellular calcium transport from apical to basolateral membranes via calcium binding at two ef-hand motifs. expression is regulated in some tissues by vitamin d.
  • S100 Calcium-Binding Protein A4

    an s100 protein characterized by four helix bundles that form n- and c-terminal ef hand motifs. it functions as a homodimer and interacts with both intracellular and extracellular signaling proteins. aberrant s100a4 activity is associated with neoplasm metastasis; fibrosis; and rheumatoid arthritis.
  • Saccharin

    flavoring agent and non-nutritive sweetener.
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases

    calcium-transporting atpases that catalyze the active transport of calcium into the sarcoplasmic reticulum vesicles from the cytoplasm. they are primarily found in muscle cells and play a role in the relaxation of muscles.
  • Selenic Acid

    a strong dibasic acid with the molecular formula h2seo4. included under this heading is the acid form, and inorganic salts of dihydrogen selenium tetraoxide.
  • Sodium-Calcium Exchanger

    an electrogenic ion exchange protein that maintains a steady level of calcium by removing an amount of calcium equal to that which enters the cells. it is widely distributed in most excitable membranes, including the brain and heart.
  • Valproic Acid

    a fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of epilepsy and bipolar disorder. the mechanisms of its therapeutic actions are not well understood. it may act by increasing gamma-aminobutyric acid levels in the brain or by altering the properties of voltage-gated sodium channels.
  • Fructose

    a monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. it is used as a preservative and an intravenous infusion in parenteral feeding.
  • Fructose Intolerance

    an autosomal recessive fructose metabolism disorder due to deficient fructose-1-phosphate aldolase (ec 2.1.2.13) activity, resulting in accumulation of fructose-1-phosphate. the accumulated fructose-1-phosphate inhibits glycogenolysis and gluconeogenesis, causing severe hypoglycemia following ingestion of fructose. prolonged fructose ingestion in infants leads ultimately to hepatic failure and death. patients develop a strong distaste for sweet food, and avoid a chronic course of the disease by remaining on a fructose- and sucrose-free diet.
  • Fructose Metabolism, Inborn Errors

    inherited abnormalities of fructose metabolism, which include three known autosomal recessive types: hepatic fructokinase deficiency (essential fructosuria), hereditary fructose intolerance, and hereditary fructose-1,6-diphosphatase deficiency. essential fructosuria is a benign asymptomatic metabolic disorder caused by deficiency in fructokinase, leading to decreased conversion of fructose to fructose-1-phosphate and alimentary hyperfructosemia, but with no clinical dysfunction; may produce a false-positive diabetes test.
  • Fructose-1,6-Diphosphatase Deficiency

    an autosomal recessive fructose metabolism disorder due to absent or deficient fructose-1,6-diphosphatase activity. gluconeogenesis is impaired, resulting in accumulation of gluconeogenic precursors (e.g., amino acids, lactate, ketones) and manifested as hypoglycemia, ketosis, and lactic acidosis. episodes in the newborn infant are often lethal. later episodes are often brought on by fasting and febrile infections. as patients age through early childhood, tolerance to fasting improves and development becomes normal.
  • Fructose-Bisphosphatase

    an enzyme that catalyzes the conversion of d-fructose 1,6-bisphosphate and water to d-fructose 6-phosphate and orthophosphate. ec 3.1.3.11.
  • Fructose-Bisphosphate Aldolase

    an enzyme of the lyase class that catalyzes the cleavage of fructose 1,6-biphosphate to form dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. the enzyme also acts on (3s,4r)-ketose 1-phosphates. the yeast and bacterial enzymes are zinc proteins. (enzyme nomenclature, 1992) e.c. 4.1.2.13.
  • Fructosediphosphates

    diphosphoric acid esters of fructose. the fructose-1,6- diphosphate isomer is most prevalent. it is an important intermediate in the glycolysis process.
  • Fructosephosphates

  • Phosphofructokinase-1

    an allosteric enzyme that regulates glycolysis by catalyzing the transfer of a phosphate group from atp to fructose-6-phosphate to yield fructose-1,6-bisphosphate. d-tagatose- 6-phosphate and sedoheptulose-7-phosphate also are acceptors. utp, ctp, and itp also are donors. in human phosphofructokinase-1, three types of subunits have been identified. they are phosphofructokinase-1, muscle type; phosphofructokinase-1, liver type; and phosphofructokinase-1, type c; found in platelets, brain, and other tissues.
  • Phosphofructokinase-2

    an allosteric enzyme that regulates glycolysis and gluconeogenesis by catalyzing the transfer of a phosphate group from atp to fructose-6-phosphate to yield fructose-2,6-bisphosphate, an allosteric effector for the other 6-phosphofructokinase, phosphofructokinase-1. phosphofructokinase-2 is bifunctional: the dephosphorylated form is a kinase and the phosphorylated form is a phosphatase that breaks down fructose-2,6-bisphosphate to yield fructose-6-phosphate.
  • Fucosyl Galactose alpha-N-Acetylgalactosaminyltransferase

    an enzyme that catalyzes the transfer of acetylgalactosamine from udp n-acetylgalactosamine to various 2-fucosylgalactosides as acceptors. ec 2.4.1.40.
  • Galactose

    an aldohexose that occurs naturally in the d-form in lactose, cerebrosides, gangliosides, and mucoproteins. deficiency of galactosyl-1-phosphate uridyltransferase (galactose-1-phosphate uridyl-transferase deficiency disease) causes an error in galactose metabolism called galactosemia, resulting in elevations of galactose in the blood.
  • Galactose Dehydrogenases

    d-galactose:nad(p)+ 1-oxidoreductases. catalyzes the oxidation of d-galactose in the presence of nad+ or nadp+ to d-galactono-gamma-lactone and nadh or nadph. includes ec 1.1.1.48 and ec 1.1.1.120.
  • Galactose Oxidase

    an enzyme that oxidizes galactose in the presence of molecular oxygen to d-galacto-hexodialdose. it is a copper protein. ec 1.1.3.9.
  • Galactosemias

    a group of inherited enzyme deficiencies which feature elevations of galactose in the blood. this condition may be associated with deficiencies of galactokinase; udpglucose-hexose-1-phosphate uridylyltransferase; or udpglucose 4-epimerase. the classic form is caused by udpglucose-hexose-1-phosphate uridylyltransferase deficiency, and presents in infancy with failure to thrive; vomiting; and intracranial hypertension. affected individuals also may develop mental retardation; jaundice; hepatosplenomegaly; ovarian failure (primary ovarian insufficiency); and cataracts. (from menkes, textbook of child neurology, 5th ed, pp61-3)
  • Galactosephosphates

    phosphoric acid esters of galactose.
  • Galectins

    a class of animal lectins that bind specifically to beta-galactoside in a calcium-independent manner. members of this class are distiguished from other lectins by the presence of a conserved carbohydrate recognition domain. the majority of proteins in this class bind to sugar molecules in a sulfhydryl-dependent manner and are often referred to as s-type lectins, however this property is not required for membership in this class.
  • Ganglioside Galactosyltransferase

    catalyzes the final step in the galactocerebroside biosynthesis pathway.
  • N-Acylsphingosine Galactosyltransferase

    an enzyme that catalyzes the conversion of udp-galactose and n-acylsphingosine to d-galactosylceramide and udp.
  • UDPglucose 4-Epimerase

    a necessary enzyme in the metabolism of galactose. it reversibly catalyzes the conversion of udpglucose to udpgalactose. nad+ is an essential component for enzymatic activity. ec 5.1.3.2.
  • UDPglucose-Hexose-1-Phosphate Uridylyltransferase

    an enzyme that catalyzes the transfer of ump from udpglucose to galactose 1-phosphate, forming udpgalactose and glucose 1-phosphate. deficiency in this enzyme is the major cause of galactosemia. ec 2.7.7.12.
  • Uridine Diphosphate Galactose

    a nucleoside diphosphate sugar which can be epimerized into udpglucose for entry into the mainstream of carbohydrate metabolism. serves as a source of galactose in the synthesis of lipopolysaccharides, cerebrosides, and lactose.
  • UTP-Hexose-1-Phosphate Uridylyltransferase

    an enzyme that catalyzes the synthesis of udpgalactose from utp and galactose-1-phosphate. it is present in low levels in fetal and infant liver, but increases with age, thereby enabling galactosemic infants who survive to develop the capacity to metabolize galactose. ec 2.7.7.10.
  • Adenosine Diphosphate Glucose

    serves as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants.
  • Blood Glucose

    glucose in blood.
  • Blood Glucose Self-Monitoring

    self evaluation of whole blood glucose levels outside the clinical laboratory. a digital or battery-operated reflectance meter may be used. it has wide application in controlling unstable insulin-dependent diabetes.
  • Endoplasmic Reticulum Chaperone BiP

    an endoplasmic reticulum specific chaperone of the hsp70 family. they are involved in folding and oligomerization of secreted and membrane proteins and endoplasmic reticulum stress related unfolded protein response.
  • Gastric Inhibitory Polypeptide

    a gastrointestinal peptide hormone of about 43-amino acids. it is found to be a potent stimulator of insulin secretion and a relatively poor inhibitor of gastric acid secretion.
  • Glucans

    polysaccharides composed of repeating glucose units. they can consist of branched or unbranched chains in any linkages.
  • Glucose

    a primary source of energy for living organisms. it is naturally occurring and is found in fruits and other parts of plants in its free state. it is used therapeutically in fluid and nutrient replacement.
  • Glucose 1-Dehydrogenase

    a glucose dehydrogenase that catalyzes the oxidation of beta-d-glucose to form d-glucono-1,5-lactone, using nad as well as nadp as a coenzyme.
  • Glucose Clamp Technique

    maintenance of a constant blood glucose level by perfusion or infusion with glucose or insulin. it is used for the study of metabolic rates (e.g., in glucose, lipid, amino acid metabolism) at constant glucose concentration.
  • Glucose Dehydrogenases

    d-glucose:1-oxidoreductases. catalyzes the oxidation of d-glucose to d-glucono-gamma-lactone and reduced acceptor. any acceptor except molecular oxygen is permitted. includes ec 1.1.1.47; ec 1.1.1.118; ec 1.1.1.119 and ec 1.1.99.10.
  • Glucose Intolerance

    a pathological state in which blood glucose level is less than approximately 140 mg/100 ml of plasma at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a glucose tolerance test. this condition is seen frequently in diabetes mellitus, but also occurs with other diseases and malnutrition.
  • Glucose Metabolism Disorders

    pathological conditions in which the blood glucose cannot be maintained within the normal range, such as in hypoglycemia and hyperglycemia. etiology of these disorders varies. plasma glucose concentration is critical to survival for it is the predominant fuel for the central nervous system.
  • Glucose Oxidase

    an enzyme of the oxidoreductase class that catalyzes the conversion of beta-d-glucose and oxygen to d-glucono-1,5-lactone and peroxide. it is a flavoprotein, highly specific for beta-d-glucose. the enzyme is produced by penicillium notatum and other fungi and has antibacterial activity in the presence of glucose and oxygen. it is used to estimate glucose concentration in blood or urine samples through the formation of colored dyes by the hydrogen peroxide produced in the reaction. (from enzyme nomenclature, 1992) ec 1.1.3.4.
  • Glucose Solution, Hypertonic

    solution that is usually 10 percent glucose but may be higher. an isotonic solution of glucose is 5 percent.
  • Glucose Tolerance Test

    a test to determine the ability of an individual to maintain homeostasis of blood glucose. it includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg).
  • Glucose Transport Proteins, Facilitative

    a family of monosaccharide transport proteins characterized by 12 membrane spanning helices. they facilitate passive diffusion of glucose across the cell membrane.
  • Glucose Transporter Type 1

    a ubiquitously expressed glucose transporter that is important for constitutive, basal glucose transport. it is predominately expressed in endothelial cells and erythrocytes at the blood-brain barrier and is responsible for glucose entry into the brain.
  • Glucose Transporter Type 2

    a glucose transport facilitator that is expressed primarily in pancreatic beta cells; liver; and kidneys. it may function as a glucose sensor to regulate insulin release and glucose homeostasis.
  • Glucose Transporter Type 3

    a major glucose transporter found in neurons.
  • Glucose Transporter Type 4

    a glucose transport protein found in mature muscle cells and adipocytes. it promotes transport of glucose from the blood into target tissues. the inactive form of the protein is localized in cytoplasmic vesicles. in response to insulin, it is translocated to the plasma membrane where it facilitates glucose uptake.
  • Glucose Transporter Type 5

    a hexose transporter that mediates fructose transport in skeletal muscle and adipocytes and is responsible for luminal uptake of dietary fructose in the small intestine.
  • Glucose-1-Phosphate Adenylyltransferase

    an atp-dependent enzyme that catalyzes the addition of adp to alpha-d-glucose 1-phosphate to form adp-glucose and diphosphate. the reaction is the rate-limiting reaction in prokaryotic glycogen and plant starch biosynthesis.
  • Glucose-6-Phosphatase

    an enzyme that catalyzes the conversion of d-glucose 6-phosphate and water to d-glucose and orthophosphate. ec 3.1.3.9.
  • Glucose-6-Phosphate

    an ester of glucose with phosphoric acid, made in the course of glucose metabolism by mammalian and other cells. it is a normal constituent of resting muscle and probably is in constant equilibrium with fructose-6-phosphate. (stedman, 26th ed)
  • Glucose-6-Phosphate Isomerase

    an aldose-ketose isomerase that catalyzes the reversible interconversion of glucose 6-phosphate and fructose 6-phosphate. in prokaryotic and eukaryotic organisms it plays an essential role in glycolytic and gluconeogenic pathways. in mammalian systems the enzyme is found in the cytoplasm and as a secreted protein. this secreted form of glucose-6-phosphate isomerase has been referred to as autocrine motility factor or neuroleukin, and acts as a cytokine which binds to the autocrine motility factor receptor. deficiency of the enzyme in humans is an autosomal recessive trait, which results in congenital nonspherocytic hemolytic anemia.
  • Glucosephosphate Dehydrogenase

  • Glucosephosphate Dehydrogenase Deficiency

    a disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of glucose-6-phosphate dehydrogenase activity in erythrocytes, leading to hemolytic anemia.
  • Glucosephosphates

  • Glycemic Control

    strategies used for regulating blood glucose levels. such strategies include administration of insulin; dietary modification; and exercise.
  • Glycogen Storage Disease Type I

    an autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. increased concentrations of lactic acid and hyperlipidemia appear in the plasma. clinical gout often appears in early childhood.
  • High Fructose Corn Syrup

    syrup made from corn used widely in foods and beverages as a cheaper alternative sweetener to sucrose (common table sugar). it is generated by enzymatic processing of natural corn syrup to produce a liquid most widely composed of 42 or 55% fructose, glucose, and various polysaccharides.
  • Incretins

    peptides which stimulate insulin release from the pancreatic beta cells following oral nutrient ingestion, or postprandially.
  • Monosaccharide Transport Proteins

    a large group of membrane transport proteins that shuttle monosaccharides across cell membranes.
  • Phosphoglucomutase

    an enzyme that catalyzes the conversion of alpha d-glucose 1-phosphate to alpha d-glucose 6-phosphate. ec 5.4.2.2.
  • Sodium-Glucose Transport Proteins

    monosaccharide transport proteins that function as active symporters. they utilize sodium or hydrogen ions to transport glucose across cell membranes.
  • Uridine Diphosphate Glucose

    a key intermediate in carbohydrate metabolism. serves as a precursor of glycogen, can be metabolized into udpgalactose and udpglucuronic acid which can then be incorporated into polysaccharides as galactose and glucuronic acid. also serves as a precursor of sucrose lipopolysaccharides, and glycosphingolipids.
  • Uridine Diphosphate Glucose Dehydrogenase

    an enzyme that catalyzes the oxidation of udpglucose to udpglucuronate in the presence of nad+. ec 1.1.1.22.
  • UTP-Glucose-1-Phosphate Uridylyltransferase

    an enzyme that catalyzes the formation of udpglucose from utp plus glucose 1-phosphate. ec 2.7.7.9.
  • Aminomethyltransferase

    a one-carbon group transferase that transfers lipoamide-linked methylamine groups to tetrahydrofolate (tetrahydrofolates) to form methylenetetrahydrofolate and ammonia. it is one of four components of the glycine decarboxylase complex.
  • Betaine

    a naturally occurring compound that has been of interest for its role in osmoregulation. as a drug, betaine hydrochloride has been used as a source of hydrochloric acid in the treatment of hypochlorhydria. betaine has also been used in the treatment of liver disorders, for hyperkalemia, for homocystinuria, and for gastrointestinal disturbances. (from martindale, the extra pharmacopoeia, 30th ed, p1341)
  • Betaine-Aldehyde Dehydrogenase

    an nad+ dependent enzyme that catalyzes the oxidation of betain aldehyde to betaine.
  • Dihydrolipoamide Dehydrogenase

    a flavoprotein containing oxidoreductase that catalyzes the reduction of lipoamide by nadh to yield dihydrolipoamide and nad+. the enzyme is a component of several multienzyme complexes.
  • Glycine Agents

    substances used for their pharmacological actions on glycinergic systems. glycinergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.
  • Glycine Decarboxylase Complex

    a enzyme complex that catalyzes the oxidative decarboxylation and deamination of glycine into carbon dioxide; ammonia; nadh; and n5n10-methylenetetrahydrofolate. it is composed of four different component protein components referred to as h, p, l, and t.
  • Glycine Decarboxylase Complex H-Protein

    a lipoic acid-containing protein that plays the pivotal role in the transfer of methylamine groups and reducing equivalents between the three enzymatic components of the glycine decarboxylase complex.
  • Glycine Dehydrogenase

    an oxidoreductase that catalyzes the oxidative deamination of glycine to glyoxylate and ammonia in the presence of nad. in bacteria lacking transaminating pathways the enzyme can act in the reverse direction to synthesize glycine from glyoxylate and ammonia and nadh.
  • Glycine Dehydrogenase (Decarboxylating)

    a pyridoxal phosphate dependent enzyme that catalyzes the decarboxylation of glycine with the transfer of an aminomethyl group to the lipoic acid moiety of the glycine decarboxylase complex h-protein. defects in p-protein are the cause of non-ketotic hyperglycinemia. it is one of four subunits of the glycine decarboxylase complex.
  • Glycine Hydroxymethyltransferase

    a pyridoxal phosphate enzyme that catalyzes the reaction of glycine and 5,10-methylene-tetrahydrofolate to form serine. it also catalyzes the reaction of glycine with acetaldehyde to form l-threonine. ec 2.1.2.1.
  • Glycine N-Methyltransferase

    an enzyme that catalyzes the methylation of glycine using s-adenosylmethionine to form sarcosine with the concomitant production of s-adenosylhomocysteine.
  • Glycine Plasma Membrane Transport Proteins

    a family of sodium chloride-dependent neurotransmitter symporters that transport the amino acid glycine. they differ from glycine receptors, which signal cellular responses to glycine. they are located primarily on the plasma membrane of neurons; glial cells; epithelial cells; and red blood cells where they remove inhibitory neurotransmitter glycine from the extracellular space.
  • Glycine Transaminase

    a pyridoxal phosphate containing enzyme that catalyzes the transfer of the amino group of glycine onto 2-oxoglutarate to generate glyoxylate and l-glutamate.
  • Glycine-tRNA Ligase

    an enzyme that activates glycine with its specific transfer rna. ec 6.1.1.14.
  • Glycochenodeoxycholic Acid

    a bile salt formed in the liver from chenodeoxycholate and glycine, usually as the sodium salt. it acts as a detergent to solubilize fats for absorption and is itself absorbed. it is a cholagogue and choleretic.
  • Glycocholic Acid

    the glycine conjugate of cholic acid. it acts as a detergent to solubilize fats for absorption and is itself absorbed.
  • Glycodeoxycholic Acid

    a bile salt formed in the liver by conjugation of deoxycholate with glycine, usually as the sodium salt. it acts as a detergent to solubilize fats for absorption and is itself absorbed. it is used as a cholagogue and choleretic.
  • Hyperglycinemia, Nonketotic

    an autosomal recessive metabolic disorder caused by deficiencies in the mitochondrial glycine cleavage system.
  • N-substituted Glycines

    amino acids composed of glycine substituted at the nitrogen rather than the usual carbon position, resulting in the loss of hydrogen bonding donors. polymers of these compounds are called peptoids.
  • Processing Bodies

    cytoplasmic rnp granules constitutively found in eukaryotic cells. various proteins related to rna regulation including rna decay are found in p-bodies. p-bodies and stress granules both sequester inactive mrnps via different pathways. in p-bodies mrnas from the stalled translational machinery are deadenylated and condensed for sequestration.
  • Propionic Acidemia

    autosomal recessive metabolic disorder caused by mutations in propionyl-coa carboxylase genes that result in dysfunction of branch chain amino acids and of the metabolism of certain fatty acids. neonatal clinical onset is characterized by severe metabolic acidemia accompanied by hyperammonemia, hyperglycemia, lethargy, vomiting, hypotonia; and hepatomegaly. survivors of the neonatal onset propionic acidemia often show developmental retardation, and intolerance to dietary proteins. late-onset form of the disease shows mild mental and/or developmental retardation, sometimes without metabolic acidemia.
  • Receptors, Glycine

    cell surface receptors that bind glycine with high affinity and trigger intracellular changes which influence the behavior of cells. glycine receptors in the central nervous system have an intrinsic chloride channel. glya receptor is sensitive to strychnine and localized in the post-synaptic membrane of inhibitory glycinergic neurons. glyb receptor is insensitive to strychnine and associated with the excitatory nmda receptor.
  • RNA, Transfer, Gly

    a transfer rna which is specific for carrying glycine to sites on the ribosomes in preparation for protein synthesis.
  • Soybeans

    an annual legume. the seeds of this plant are edible and used to produce a variety of soy foods.
  • Theophylline

    a methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. theophylline inhibits the 3',5'-cyclic nucleotide phosphodiesterase that degrades cyclic amp thus potentiates the actions of agents that act through adenylyl cyclases and cyclic amp.
  • beta-Fructofuranosidase

    a glycoside hydrolase found primarily in plants and yeasts. it has specificity for beta-d-fructofuranosides such as sucrose.
  • Dietary Sucrose

    sucrose present in the diet. it is added to food and drinks as a sweetener.
  • Sucrase

    digestive enzyme secreted in the intestines. it catalyzes hydrolysis of sucrose to fructose and glucose.
  • Sucrose

    a nonreducing disaccharide composed of glucose and fructose linked via their anomeric carbons. it is obtained commercially from sugarcane, sugar beet (beta vulgaris), and other plants and used extensively as a food and a sweetener.

Coding Guidelines

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined. If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances (T50). Use the following options for the aplicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.


Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Poisoning by electrolytic, caloric and water-balance agents NOS

Table of Drugs and Chemicals

The code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.

According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.

Substance Poisoning
Accidental
(unintentional)
Poisoning
Accidental
(self-harm)
Poisoning
Assault
Poisoning
Undetermined
Adverse
effect
Underdosing
Amino acidsT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Aminoacetic acid (derivatives)T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
AntikalureticT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
CalciumT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »actylsalicylate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »benzamidosalicylate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »bromide
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »bromolactobionate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »carbaspirin
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »carbimide
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »carbonate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »chloride
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »chloride
    »anhydrous
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »cyanide
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »dioctyl sulfosuccinate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »disodium edathamil
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »disodium edetate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »dobesilate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »EDTA
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »ferrous citrate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »folinate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »glubionate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »gluconate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »gluconogalactogluc-onate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »hydrate, hydroxide
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »hypochlorite
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »iodide
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »ipodate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »lactate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »leucovorin
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »mandelate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »oxide
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »pantothenate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »phosphate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »salicylate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Calcium
  »salts
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Caloric agentT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Carbacrylamine (resin)T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Cation exchange resinT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
DextroseT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Dextrose
  »concentrated solution, intravenous
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Dialysis solution (intraperitoneal)T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Electrolyte balance drugT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Electrolytes NECT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Electrolytic agent NECT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
FructoseT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
GalactoseT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
GlucoseT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Glucose
  »with sodium chloride
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
GlycineT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Hartmann's solutionT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Invert sugarT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Lactated potassic salineT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
LevuloseT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Oral rehydration saltsT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Peritoneal dialysis solutionT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Polyaminostyrene resinsT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassic saline injection (lactated)T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NECT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »aminobenzoate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »aminosalicylate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »antimony ' tartrate'
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »arsenite (solution)
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »bichromate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »bisulfate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »bromide
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »canrenoate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »carbonate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »chlorate NEC
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »chloride
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »citrate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »cyanide
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »ferric hexacyanoferrate (medicinal)
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »ferric hexacyanoferrate (medicinal)
    »nonmedicinal
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »Fluoride
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »glucaldrate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »hydroxide
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »iodate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »iodide
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »nitrate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »oxalate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »perchlorate (nonmedicinal) NEC
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »perchlorate (nonmedicinal) NEC
    »antithyroid
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »perchlorate (nonmedicinal) NEC
    »medicinal
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »Permanganate (nonmedicinal)
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »Permanganate (nonmedicinal)
    »medicinal
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium (salts) NEC
  »sulfate
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium-removing resinT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Potassium-retaining drugT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Rehydration salts (oral)T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Replacement solutionT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Ringer (lactate) solutionT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Sodium-removing resinT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
SucroseT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
TravertT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
WaterT50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Water
  »balance drug
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Water
  »distilled
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Water
  »gas
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Water
  »gas
    »incomplete combustion of
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Water
  »hemlock
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Water
  »moccasin (venom)
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6
Water
  »purified
T50.3X1T50.3X2T50.3X3T50.3X4T50.3X5T50.3X6

Patient Education


Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

  • Knowing your medicines. When you get a prescription, ask the name of the medicine and check to make sure that the pharmacy gave you the right medicine. Make sure that you understand how often you should take the medicine and how long you should take it.
  • Keeping a list of medicines.
    • Write down all of the medicines that you are taking, including the names of your medicines, how much you take, and when you take them. Make sure to include any over-the-counter medicines, vitamins, supplements, and herbs that you take.
    • List the medicines that you are allergic to or that have caused you problems in the past.
    • Take this list with you every time you see a health care provider.
  • Reading medicine labels and following the directions. Don't just rely on your memory - read the medication label every time. Be especially careful when giving medicines to children.
  • Asking questions. If you don't know the answers to these questions, ask your health care provider or pharmacist:
    • Why am I taking this medicine?
    • What are the common side effects?
    • What should I do if I have side effects?
    • When should I stop this medicine?
    • Can I take this medicine with the other medicines and supplements on my list?
    • Do I need to avoid certain foods or alcohol while taking this medicine?

Food and Drug Administration


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.